EU Parliament OK's Rules For Gene Therapy Industry

Law360, New York (April 25, 2007, 12:00 AM EDT) -- The European Parliament on Wednesday voted in favor of establishing EU-wide rules to regulate new gene, cell and tissue therapies, in an effort to ensure product safety and to foster cross-border competition.

The rules on advanced therapies would only be limited to regulating safety, competition and access for patients, and would not address the prickly ethical issues surrounding new medical technology, the European Commission said.

“Today’s Parliament vote paves the way for an early adoption of this eagerly-awaited regulation, which patients and the industry have been...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.